JPMorgan Chase & Co’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $182K | Sell |
83,398
-8,926
| -10% | -$19.5K | ﹤0.01% | 4507 |
|
|
2025
Q1 | $252K | Sell |
92,324
-59,626
| -39% | -$163K | ﹤0.01% | 4348 |
|
|
2024
Q4 | $632K | Sell |
151,950
-42,049
| -22% | -$175K | ﹤0.01% | 4045 |
|
|
2024
Q3 | $755K | Sell |
193,999
-15,573
| -7% | -$60.6K | ﹤0.01% | 3794 |
|
|
2024
Q2 | $822K | Sell |
209,572
-32,000
| -13% | -$125K | ﹤0.01% | 3605 |
|
|
2024
Q1 | $1.01M | Buy |
241,572
+893
| +0.4% | +$3.74K | ﹤0.01% | 3564 |
|
|
2023
Q4 | $1.13M | Sell |
240,679
-117,148
| -33% | -$551K | ﹤0.01% | 3455 |
|
|
2023
Q3 | $1.12M | Sell |
357,827
-3,311
| -0.9% | -$10.3K | ﹤0.01% | 3338 |
|
|
2023
Q2 | $1.66M | Sell |
361,138
-18,717
| -5% | -$85.9K | ﹤0.01% | 3143 |
|
|
2023
Q1 | $1.88M | Buy |
379,855
+73,298
| +24% | +$363K | ﹤0.01% | 3076 |
|
|
2022
Q4 | $1.67M | Buy |
306,557
+37,797
| +14% | +$206K | ﹤0.01% | 3067 |
|
|
2022
Q3 | $1.75M | Buy |
268,760
+10,608
| +4% | +$68.9K | ﹤0.01% | 3008 |
|
|
2022
Q2 | $1.22M | Buy |
258,152
+149,266
| +137% | +$705K | ﹤0.01% | 3333 |
|
|
2022
Q1 | $762K | Buy |
108,886
+7,647
| +8% | +$53.5K | ﹤0.01% | 3772 |
|
|
2021
Q4 | $1.03M | Buy |
101,239
+81,613
| +416% | +$832K | ﹤0.01% | 3652 |
|
|
2021
Q3 | $239K | Buy |
+19,626
| New | +$239K | ﹤0.01% | 4329 |
|